Diabetic Ketoacidosis in a Type 2 Diabetes Patient After Initiation of Over-the-Counter Weight Loss Medications: A Cautionary Tale

Kamilya A. Gosmanova; Aidar R. Gosmanov

doi:10.2337/cd20-0024

Case Studies

Diabetic Ketoacidosis in a Type 2 Diabetes Patient After Initiation of Over-the-Counter Weight Loss Medications: A Cautionary Tale

Kamilya A. Gosmanova¹ and
Aidar R. Gosmanov¹,²

¹Albany Medical College, Albany, NY
²Section of Endocrinology, Stratton VA Medical Center, Albany, NY

Corresponding author: Aidar R. Gosmanov, aidar.gosmanov{at}va.gov or agosmanov{at}gmail.com

Clinical Diabetes 2020 Oct; 38(4): 408-411. https://doi.org/10.2337/cd20-0024

Article Information

vol. 38 no. 4 408-411

DOI

https://doi.org/10.2337/cd20-0024

Published By

American Diabetes Association

Print ISSN

0891-8929

Online ISSN

1945-4953

History

Published in print October 15, 2020.
Published online ahead of print August 7, 2020.

Article Versions

Previous version (August 7, 2020 - 12:11).
You are viewing the most recent version of this article.

© 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.